DNTH Next Earnings Date Notes

— Dianthus Therapeutics (ticker symbol: DNTH) is a clinical-stage biopharmaceutical company focused on developing next-generation antibody therapeutics that target the complement system, a key part of the immune response implicated in serious autoimmune & inflammatory diseases. DNTH's lead program, DNTH103, is designed as a potent, selective C1s inhibitor for the treatment of complement-mediated disorders such as generalized myasthenia gravis (gMG) and other related conditions. As you prepare for the next DNTH earnings call, the most relevant business metrics to track include pipeline progress—especially updates regarding enrollment, clinical milestones, & data from ongoing or planned clinical trials for DNTH103. Additionally, keep an eye on cash runway & operating expenses, since clinical progress is heavily dependent on prudent use of capital. Strategic updates, such as news related to regulatory conversations, potential partnerships, & expansion of the pipeline beyond DNTH103, are also crucial for evaluating longer-term potential. Tracking these aspects will provide the best insight into DNTH's underlying execution & prospects in the competitive biotech landscape. The next projected earnings date for DNTH is 8/7/2026 after close (stay tuned for a confirmed earnings date once announced).

DNTH Next Earnings Date FAQ

On this page we presented the DNTH Next Earnings Date information for Dianthus Therapeutics along with recent past earnings dates. For Q1 of 2026, DNTH reported earnings of -0.850/share, with the earnings report taking place on 5/5/2026. For Q4 of 2025, DNTH reported earnings of -1.430/share, with the earnings report taking place on 3/9/2026. For Q3 of 2025, DNTH reported earnings of -0.970/share, with the earnings report taking place on 11/5/2025. For Q2 of 2025, DNTH reported earnings of -0.880/share, with the earnings report taking place on 8/7/2025. For Q1 of 2025, DNTH reported earnings of -0.820/share, with the earnings report taking place on 5/12/2025. Based on these past earnings dates, the projected next earnings date for DNTH is 8/7/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Dianthus Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Dianthus Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Dianthus Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next DNTH earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up DNTH's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the DNTH next earnings date.